GBA Antibodies
The glucocerebrosidase (GBA) gene mutation is a very important and common risk factor for Parkinson's disease (PD). Some Gaucher disease (GD) patients and GBA mutation carriers are prone to develop PD. In addition, the frequency of PD patients carrying GBA mutations is also greatly increased. In most PD patients, GBA mutations are more common than other PD-related genes.
Elucidating the mechanism of the association between GBA mutations and PD will provide new and important insights into the treatment of PD. Current hypotheses and models have significant limitations, so we need to combine cell biology, neuropathology, and genetics to further study GBA-related PD and elucidate its pathogenesis and other risk factors that promote PD. Our antibodies are powerful tools for your research to propose new therapeutic strategies for this common disease and other neurodegenerative disorders, and to mitigate or prevent the progression of these diseases.
GBA Mutations and PD
- GBA mutation promotes α-synuclein aggregation. Mutant GBA and α-synuclein co-localize in protein aggregates in the brains of PD patients. Another study found that in brain samples from PD patients carrying GBA mutations, GBA was present in 33% to 90% of Lewy bodies, with an average of 75%, while in PD patients without GBA mutations, GBA was present in less than 10% of Lewy bodies.
- GBA mutation influences the autophagy-lysosome pathway. Mice with the homozygous GBA mutation V394L and deficiency of protein kinase C are a model for GD. By observing the axons in the mouse brain, the researchers found some aggregates in the axons where the autophagy markers LAMP-2 and p62 were present, suggesting that GBA mutations could lead to impaired autophagy and cause axonal degeneration.
- GBA mutation affects the ubiquitin-proteasome system. PARK2 encodes the E3 ubiquitin ligase parkin. Mutations in this gene lead to parkin dysfunction, which is associated with juvenile-onset autosomal inherited PD. Studies have shown that both wild-type GBA and the N370S mutant GBA can interact with parkin, suggesting that the interaction between mutant GBA and parkin prevents parkin from interacting with its substrate, thereby disrupting the ubiquitin-proteasome system and ultimately leading to endoplasmic reticulum stress and cell death.
Fig.1 Possible mechanism for the link between GBA mutation and PD1,2.
GBA Antibodies Selection Guide
Choose the most appropriate GBA antibody for your research from Creative Biolabs' GBA antibodies library, which is suitable for a variety of applications and can bind to GBA in human, rat, and mouse. If you can't find the antibody you need, contact us now to develop custom antibodies for specific targets, species, and applications.
Cat. No | Product Name | Host | Application |
NAB-0720-Z5453 | Rabbit Anti-GBA Monoclonal Antibody (CBP3048) | Rabbit | WB; IHC-P |
NAB-0720-Z5456 | Rabbit Anti-GBA Monoclonal Antibody (CBP3051) | Rabbit | WB; IHC-P |
NAB-0720-Z5458 | Mouse Anti-GBA Monoclonal Antibody (CBP3053) | Mouse | WB; IHC-P; IHC-Fr; ICC; IF |
NRZP-0223-ZP222 | Anti-GBA/Glucosylceramidase Monoclonal Antibody, (CBP17909) | Rabbit | WB |
References
- Smith, Laura, and Anthony HV Schapira. "GBA variants and Parkinson disease: mechanisms and treatments." Cells 11.8 (2022): 1261.
- Image retrieved from Figure 2 "Possible mechanisms underlying the link between GCase, alpha-synuclein and PD." Smith et al., 2022, used under [CC BY 4.0]. The title was changed to "Possible mechanism for the link between GBA mutation and PD."
- NeuroMab™ Anti-GARP Antibody(NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1686) (Cat#: NRP-0422-P1686)
- NeuroMab™ Anti-CD20 Antibody(NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- NeuroMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- NeuroMab™ Anti-Alpha Synuclein Antibody(NRP-0422-P614) (Cat#: NRP-0422-P614)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- NeuroMab™ Anti-CD32b Antibody(NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- NeuroMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- NeuroMab™ Anti-GD2 Antibody(NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Human CMEC/D3 Cell Line, Blood-Brain Barrier Model (Cat#: NCL-2108-P020)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- iNeu™ Retinal Pigment Epithelial Cells (RPE) (Cat#: NRZP-0323-ZP92)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- pAAV-syn-jGCaMP8f-WPRE (Cat#: NTA-2106-P061)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- AAV2/2Retro-CAG-DIO-EGFP-2A-TetTox-pA [Neural Tracing] (Cat#: NTA-2012-ZP303)
- Dextran-CYanine5.5 (Cat#: NTA-2011-ZP118)
- AAV2/9-hSyn-Flpo-EGFP-WPRE-pA (Cat#: NTA-2012-ZP149)
- pAAV-syn-FLEX-jGCaMP8s-WPRE (Cat#: NTA-2106-P066)
- PRV-CAG-EGFP (Cat#: NTA-2011-ZP14)
- Dextran-FITC (Cat#: NTA-2011-ZP110)
- pAAV-hSyn-DIO-XCaMP-R-WPRE (Cat#: NTA-2012AD-P508)
- pAAV-EF1a-DIO-EGFP-WPRE (Cat#: NTA-2012AD-P285)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)